The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-ninth adult lung transplantation report-2022; focus on lung transplant recipients with chronic obstructive pulmonary disease

Michael Perch, Don Hayes Jr, Wida S Cherikh, Andreas Zuckermann, Michael O Harhay, Eileen Hsich, Luciano Potena, Aparna Sadavarte, Kelsi Lindblad, Tajinder P Singh, Josef Stehlik, International Society for Heart and Lung Transplantation, Michael Perch, Don Hayes Jr, Wida S Cherikh, Andreas Zuckermann, Michael O Harhay, Eileen Hsich, Luciano Potena, Aparna Sadavarte, Kelsi Lindblad, Tajinder P Singh, Josef Stehlik, International Society for Heart and Lung Transplantation

No abstract available

Keywords: COPD; lung transplantation; morbidity; post-transplant survival; recipient characteristics; registry.

Figures

Figure 1

Diagnosis distribution by location and era (transplants: January 1992-June 2018).

Figure 2

Median recipient A) age and B) body mass index (BMI) by location (COPD transplants: January 1992-June 2018).

Figure 3

Relative incidence of leading causes of death (COPD transplant deaths: January 2010-June 2018).

Figure 4

Cumulative incidence of leading causes of death (COPD transplants: January 2010-June 2017).

Figure 5

Kaplan-Meier survival within 12 months by era (COPD transplants: January 2000-June 2017).

Figure 6

Kaplan-Meier survival within 12 months by diagnosis (transplants: January 2000-June 2017).

Figure 7

Kaplan-Meier survival within 12 months by age and procedure type (COPD transplants: January 2000-June 2017).

Figure 8

Kaplan-Meier survival within 5 years conditional on survival to 1 year by recipient age (COPD transplants: January 1996-June 2013).

Figure 9

Kaplan-Meier survival within 5 years conditional on survival to 1 year by diagnosis (transplants: January 1996-June 2013).

Figure 10

Kaplan-Meier survival within 5 years conditional on survival to 1 year by recipient age and procedure type (COPD transplants: January 2000-June 2017).

Figure 11

Freedom from BOS/CLAD conditional on survival to discharge by procedure type (COPD transplants: January 1996-June 2013).

Figure 12

Freedom from new onset of A) lung cancer and B) non-lung cancer, conditional on survival to 1 year by procedure type (COPD transplants: January 1996-June 2017).

Figure 13

Multivariable hazard ratio plot for 1-year mortality with 95% confidence limits, by recipient age (COPD transplants: January 2000-June 2017; N = 15,643).

Figure 14

Multivariable hazard ratio plot for 5-year mortality conditional on survival to 1 year with 95% confidence limits, by A) recipient age and B) recipient body mass index (BMI) (COPD transplants: January 1996-June 2013; N = 11,683).

Figure 15

Statistically significant risk factors for BOS/CLAD within 5 years conditional on survival to discharge with 95% confidence limits (COPD transplants: January 1996-June 2013; N = 6,181).

Figure 16

Statistically significant risk factors for BOS/CLAD within 5 years conditional on survival to discharge with 95% confidence limits, by PRA (COPD transplants: January 1996-June 2013; N = 6,181).